Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

A mix of specific inhibitors and a growth factor helps keep hair growth cells from losing their properties in the lab.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Nilotinib can cause skin issues like red bumps and hair loss.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

New RIPK4 gene mutations were found to cause a type of skin and limb birth defect.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Mutant MK6a transgenes in mice cause blistering, hair loss, and potential human alopecia.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Applying a specific inhibitor lightens skin and hair color.